Effect of Citalopram on Agitation in Alzheimer's Disease – The CitAD Randomized Controlled Trial

IMPORTANCE: Agitation is common, persistent, and associated with adverse consequences for patients with Alzheimer's disease (AD). Pharmacological treatment options, including antipsychotics are not satisfactory. OBJECTIVE: The primary objective was to evaluate the efficacy of citalopram for agi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Porsteinsson, Anton P., Drye, Lea T., Pollock, Bruce G., Devanand, D.P., Frangakis, Constantine, Ismail, Zahinoor, Marano, Christopher, Meinert, Curtis L., Mintzer, Jacobo E., Munro, Cynthia A., Pelton, Gregory, Rabins, Peter V., Rosenberg, Paul B., Schneider, Lon S., Shade, David M., Weintraub, Daniel, Yesavage, Jerome, Lyketsos, Constantine G.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4086818/
https://ncbi.nlm.nih.gov/pubmed/24549548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2014.93
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky